Recently, there have been reports that Johnson&Johnson China has laid off multiple product lines, with compensation plans ranging from "N+1", "N+2", and "N+3". An employee of Johnson&Johnson China wh ...

Citigroup has raised Johnson&Johnson's target price from $180 to $185.

Southern Finance and Economics, September 23rd - According to Tianyancha App, Johnson&Johnson (China) Investment Co., Ltd. has undergone a business change recently, with Song Weiqun stepping down as ...

According to the Tianyancha App, on September 18th, Johnson&Johnson (China) Investment Co., Ltd. underwent a business change, with Song Weiqun stepping down as the legal representative and chairman, ...

Johnson&Johnson announced on July 15th that Edward Zhou will serve as the President of its Medical Technology China region from July 25th, 2024, reporting to Vishnu Karla, the Chairman of Johnson&Joh ...

Johnson&Johnson subsidiary responds to "shortage of focus on delivery in many areas": the company is facing supply pressure and challenges due to a significant increase in market demand. Recently, th ...

Recently, Kenvue (KVUE. US) announced on its official website that Johnson&Johnson (JNJ. US) will sell its remaining 9.5% stake in the company to Goldman Sachs and JPMorgan Chase in a debt to equity ...

On May 16th, Johnson&Johnson announced that they had reached a final agreement with Proteology to acquire biotechnology company Proteology for $850 million in cash. The transaction is expected to be ...

One year after landing on the New York Stock Exchange, Kenvue, originally a consumer health business company for Johnson&Johnson, pressed the layoff button. On May 7th US time, Kenvue released its Q1 ...

Johnson&Johnson announced on May 1st a restructuring plan proposed by its subsidiary LLT Management LLC (LLT) to comprehensively and ultimately resolve all current and future claims related to ovaria ...

Johnson&Johnson announced on May 1st a restructuring plan proposed by its subsidiary LLT Management LLC (LLT) to comprehensively and ultimately resolve all claims related to ovarian cancer in current ...

On April 5th, Johnson&Johnson and Shockwave Medical announced a final agreement to acquire all outstanding shares of Shockwave in cash at a price of $335 per share. The total value of this transactio ...

On January 23rd, Johnson&Johnson (NYSE: JNJ) released its fourth quarter and full year results for 2023. In the fourth quarter of 2023, the company reported sales of 21.4 billion US dollars, a year-o ...

On January 8th, Bloomberg reported that insiders revealed that Johnson&Johnson (J&J) had initially agreed to pay approximately $700 million (approximately RMB 5 billion) to resolve an investigation i ...

On January 8th, Bloomberg reported, citing sources familiar with the matter, that Johnson&Johnson (NYSE: JNJ) has tentatively agreed to pay approximately $700 million (approximately RMB 5 billion) to ...

Erik Haas, the global vice president in charge of litigation at Johnson&Johnson, stated during an investor conference call on December 5th local time that the company has recently reached a settlemen ...

Johnson&Johnson CEO Joaquin Duato stated at the company's Investor Day event on December 5th that the company currently has no plans to produce weight loss pills due to the intense competition in the ...